Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) EBT Margin (2016 - 2025)

Biomerica's EBT Margin history spans 16 years, with the latest figure at 108.6% for Q4 2025.

  • For Q4 2025, EBT Margin fell 5034.0% year-over-year to 108.6%; the TTM value through Nov 2025 reached 90.08%, up 1022.0%, while the annual FY2025 figure was 93.62%, 1600.0% up from the prior year.
  • EBT Margin for Q4 2025 was 108.6% at Biomerica, down from 0.36% in the prior quarter.
  • Across five years, EBT Margin topped out at 0.36% in Q3 2025 and bottomed at 632.99% in Q2 2021.
  • The 5-year median for EBT Margin is 106.49% (2025), against an average of 121.9%.
  • The largest annual shift saw EBT Margin plummeted -60300bps in 2021 before it skyrocketed 60000bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 24.16% in 2021, then tumbled by -354bps to 109.65% in 2022, then increased by 13bps to 95.66% in 2023, then soared by 39bps to 58.25% in 2024, then plummeted by -86bps to 108.6% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's EBT Margin are 108.6% (Q4 2025), 0.36% (Q3 2025), and 205.47% (Q2 2025).